Inovio, a biotechnology firm that develops electroporation-based systems for in vivo gene and bio-molecule delivery, said this week that it has appointed David Pyrce as its chief business officer.

Pyrce comes to Inovio from Vical, where he served as vice president of corporate development. Prior to that, he was general partner at Bear Creek Capital Management and served as vice president and senior healthcare analyst at First Security, Van Kasper & Co.